An Individualized Approach to Biologic Therapy for IBD Using a Patient Online Decision Tool

Friday, June 30, 2017, 12:00 AM - Tuesday, June 30, 2020, 11:59 PM PST, Los Angeles

The care of the patient with inflammatory bowel disease (IBD) is complex, with treatment options that may equally allow for differing treatment strategies. Understanding how patients with IBD assess the risks, benefits, quality of life, convenience, and cost trade-offs when they decide among the various biologic treatment options can help guide clinicians in clinical decision-making. This online CME activity is designed to aid clinicians who treat patients with IBD in identifying what matters most (i.e., mode of administration, effectiveness, etc.) to IBD patients when they decide among the different biologics.  

To access this free online activity, please click the "Content & Tests" button above.

1. Optimize therapy for patients with IBD by learning about patient-reported experiences
2. Summarize the side effects and concerns most commonly described by patients
3. Describe which factors patients value most when making decisions about using biologic therapies for IBD
4. Learn about the discrepancies between what physicians value when they prescribe biologics and what patients value with regards to biologic therapies

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Acknowledgement of Commercial Support: Cedars-Sinai Medical Center gratefully acknowledges an educational grant in support of this educational activity from Takeda Pharmaceuticals U.S.A., Inc.

AMA PRA Category 1 Credit(s)™ (MD, DO) (1.00 hours), Non-Physician AMA Attendance (1.00 hours)